Intravenous Access Devices; Used to Draw Blood and to Deliver Intravenous Fluids, Drugs, or Blood Transfusions

 

Intravenous Access Devices
Intravenous Access Devices

Intravenous access devices are medical device used to deliver fluids, drugs, and blood products to the patient. These devices are used by physicians for the diagnosis of a patient's condition and for treatment. The devices are also used to test the patient's blood. They may be used for the delivery of a variety of drugs, such as analgesics, medicines for respiratory disorders, and other treatments. The use of intravenous access devices is increasing due to a number of reasons. One of the primary reasons is the increased prevalence of chronic diseases.

Global Intravenous Access Devices Market size was valued at US$ 39,834.8 million in 2019, and is expected to witness a CAGR of 6.7% over the forecast period (2019 – 2027).

Intravenous access devices are used by doctors to deliver medicine to the blood stream through IV (intravenous) route. They can also be used to withdraw blood for testing or diagnosis. Moreover, IV access devices are widely used for blood transfusion, fluid replacement, to deliver medications, and to correct the electrolyte imbalances. They are placed under skin in a skin pocket, on the chest wall or on/under the upper arm, depending on the patient's preference. The catheter is inserted into the central vein, and the port allowing access to the catheter is located just under the skin.

IV access devices, such as IV catheters, IV needles, IV infusion pumps, and catheters, are inserted into veins for people who need frequent access to the bloodstream. These devices are usually placed in one of the larger veins in a chest or neck, so they may remain in place for weeks, months, or longer. IV access devices are used to administer drugs to treat variety of chronic diseases, such as cardiovascular disorders, cancer, diabetes, and more. Thus, there is an increasing demand for Intravenous access devices around the world.

The U.S. Food and Drug Administration (FDA) has granted marketing authorization for the use of the Ellipsys Vascular Access System and the everlinQ endoAVF System to make what’s called an arteriovenous (AV) fistula for patients who need hemodialysis access.

Comments

Post a Comment

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular techn
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories of a
Read more

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk

Image
  Organic Milk Organic Milk is milk made from livestock raised using organic farming practices. The use of the term "organic" is regulated by food authorities in most jurisdictions. Organic cows are not allowed to be given hormones, which stimulate milk production. Organic feed also must be grown without the use of synthetic pesticides. Organic cows must get a certain percentage of their diet from grazing, although most organic dairies supplement the grass with grain. However, organic grazing cows produce less milk than cows that eat a grain-based diet. Buying organic milk may be a better investment for your health. According to Coherent Market Insights the Organic Milk Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. The standards for organic milk are stringent. To meet the organic standard, a dairy farm cannot use any form of animal growth hormones or antibiotics. Organic cows must spend at least 30% of their lives on pasture. C
Read more